$675 List Price, $25 Copays: U.S. Semaglutide Cost 2026–2027

September 2, 2026
Medication cartons and coins at pharmacy counter

Most U.S. patients pay a wide range for semaglutide, from very low copays to full list price, influenced by insurance coverage, manufacturer savings cards, and product type, and the gap comes down to three things: whether insurance covers it, whether you qualify for a manufacturer savings card, and whether you’re buying brand-name or a compounded version. Manufacturer list prices are also set to drop sharply, with Novo Nordisk announcing a reduction to $675 per month starting January 1, 2027.

TL;DR:

  • Patients with insurance may pay as little as $25 monthly with savings programs, but caps and eligibility rules limit savings for many.
  • List prices for semaglutide currently range from $1,000 to $1,350 per month, dropping to $675 in 2027 for brand-name products.
  • Compounded semaglutide can cost significantly less but carries risks unless sourced from FDA-registered pharmacies with proper oversight.
  • Medicare and federal programs often have higher out-of-pocket costs, with recent changes offering some low-cost options for eligible beneficiaries.
  • Accurate cost estimation requires multiple calls to insurers and pharmacies, and using HSA or FSA accounts can help lower final expenses.

Table of Contents

Semaglutide Cost Tiers: List Price, Self-Pay, Savings Cards, and Compounding

The number you see quoted for semaglutide depends almost entirely on which “price” someone is talking about. List price, also called wholesale acquisition cost (WAC), is the sticker price manufacturers set before any discount, rebate, or insurance adjustment touches it. Right now, brand-name semaglutide products run roughly $1,000 to $1,350 a month at list price, according to industry pricing data. That figure is dropping to $675 across Wegovy, Ozempic, and Rybelsus starting in 2027. Almost nobody actually pays list price out of pocket. It matters mainly because high-deductible health plans and coinsurance percentages are often calculated against it.

Semaglutide monthly cost tier comparison

Below list price sits NovoCare self-pay, the manufacturer’s direct-to-patient cash option for people without coverage. Wegovy’s official pricing page lists introductory self-pay offers that commonly land between $199 and $499 a month, depending on dose and whether it’s a first fill or a refill. Then there’s the savings card tier, reserved for patients with commercial insurance whose plan already covers a GLP-1 medication. Ozempic’s savings program can bring a covered patient’s copay down to as little as $25 a month, though annual savings caps and eligibility rules apply.

Compounded semaglutide through telehealth platforms is usually lower in cost, often significantly less than branded pricing, largely because compounding avoids the branded manufacturing and marketing costs baked into Ozempic or Wegovy pricing.

Three realistic scenarios show how differently this plays out:

  • An uninsured patient using NovoCare self-pay pricing might pay a moderate amount for Wegovy, depending on dose.
  • A commercially insured patient whose plan covers Ozempic and who qualifies for the savings card could pay a very low copay, assuming they haven’t exceeded the annual cap.
  • A patient on a high-deductible health plan may pay close to full list price until the deductible is met, then shift to a copay or coinsurance percentage for the rest of the year.

How Semaglutide Insurance Coverage and Savings Programs Actually Work

Whether your plan covers semaglutide, and what you owe when it does, depends on a chain of decisions made by your insurer’s pharmacy benefit manager (PBM) long before you ever fill a prescription. Formularies sort drugs into tiers, and GLP-1 medications for weight loss often sit on a higher tier than the same drug prescribed for diabetes, even though the medication is identical. Many plans also require prior authorization, meaning your doctor has to submit documentation proving medical necessity before the insurer will pay anything.

Once a plan agrees to cover semaglutide, your actual bill depends on your benefit design. A copay is a flat dollar amount per fill. Coinsurance is a percentage of the drug’s cost, which is why list price still matters even for insured patients. And if you haven’t met your deductible yet, you may be responsible for the full negotiated rate until you do.

Manufacturer savings cards fill some of the gap between insurance and full price, but they come with real restrictions worth understanding before you count on one:

  1. Confirm your insurance already covers the medication. Savings cards typically supplement existing commercial coverage rather than replacing it.
  2. Check the annual savings cap. Most programs cap total savings at a set dollar amount per year, after which you’re back to your plan’s standard cost-sharing.
  3. Verify you’re not enrolled in Medicare, Medicaid, or another federal health program. Manufacturer savings cards are almost universally restricted to commercially insured patients.
  4. Ask your pharmacy to run the card at the point of sale rather than assuming eligibility from the program’s website alone.

The fastest way to get a real number, rather than a guess, is a three-call process: your insurer’s member services line, the PBM’s website (often listed on your insurance card), and the pharmacy that will actually fill the prescription. Pharmacies see the adjudicated price in real time, which makes them a surprisingly reliable second opinion when your insurer’s answer sounds vague.

Pro Tip: Get the name of the representative and a reference number every time you call about prior authorization. If your claim gets denied later, that reference number is often the difference between a quick appeal and starting the entire process over.

Does the Injectable Pen or the Pill Cost More Each Month?

Semaglutide comes in two forms, and the packaging difference alone explains a chunk of the price variation you’ll see between quotes. Ozempic and Wegovy are injectable pens, dosed weekly and sold in boxes containing a fixed number of doses per strength. Rybelsus is an oral tablet taken daily, sold in monthly bottles. FDA labeling documents specify exact milligram content per pen and per tablet, and that packaging structure is part of why oral and injectable pricing rarely match exactly, even at similar doses.

Dose escalation is the bigger driver of month-to-month cost changes for patients already on the drug. Semaglutide treatment starts low and increases over weeks to reduce nausea and other side effects, and each dose increase can mean a different pen strength or a new tier of tablet dosage:

  • Starting doses (0.25mg injectable or 3mg oral) are typically the cheapest fill, since manufacturers often price entry-level strengths lower to support the titration schedule.
  • Mid-range maintenance doses (1mg to 1.7mg injectable, 7mg to 14mg oral) usually cost more per box, since patients need a higher-concentration pen or a larger tablet.
  • Higher maintenance doses (2mg or 2.4mg injectable) sit at the top of the pricing range for that product, often costing noticeably more per fill than the starting dose.

If your first pharmacy quote seems low, ask whether it reflects your eventual maintenance dose or just your starter pack. That single question prevents a lot of billing surprises three months into treatment.

Is Compounded Semaglutide Safe, and Why Is It Cheaper?

Compounded semaglutide costs less than branded versions, mainly because compounding pharmacies aren’t paying for the branded manufacturing, marketing, and distribution infrastructure that inflates Ozempic and Wegovy pricing. That price gap is real, but it only translates to a safe purchase when the compounding pharmacy meets specific standards.

The FDA has issued public warnings about unapproved GLP-1 products circulating outside legitimate pharmacy channels, flagging dosing inconsistencies and contamination risks in products sourced from unregulated sellers. That’s the risk a bargain price can be hiding.

Before trusting a lower quote, check for these five things:

  • A licensed clinician actually reviews your medical history before prescribing, rather than approving a form automatically.
  • The compounding pharmacy is FDA-registered, not an offshore or unregistered lab.
  • The provider can show third-party purity testing or a certificate of analysis for the specific batch.
  • Shipping and delivery timelines are stated clearly, with tracking, not vague promises.
  • You have ongoing access to a clinician for dose adjustments or side-effect questions after your first shipment.

If you have a complex medical history, are pregnant, or have a personal or family history of medullary thyroid carcinoma, FDA-approved branded therapy under close physician supervision is generally the more appropriate route, compounded or not.

Medicare, Medicaid, and VA Rules That Change Your Semaglutide Copay

Federal health programs play by different rules than commercial insurance, and 2026 through 2027 brings some real changes worth tracking if you’re on Medicare, Medicaid, or VA care.

Medicare Part D coverage for semaglutide varies significantly by plan, and manufacturer savings cards generally don’t apply to Medicare beneficiaries at all, since those programs are restricted to commercially insured patients. That’s historically left Medicare patients facing much higher out-of-pocket costs than someone with employer coverage. The Medicare GLP-1 Bridge program changes that picture for a defined window: eligible Part D beneficiaries can access Wegovy for a low monthly cost between July 1, 2026, and December 31, 2027, though enrollment and eligibility rules apply.

A few other program-specific notes worth checking before you assume a price:

  • Medicaid coverage for GLP-1 medications varies by state, so confirm your specific state’s formulary rather than relying on national coverage headlines.
  • Veterans should consult VA formulary guidance directly, since VA coverage criteria for semaglutide differ from both Medicare and commercial plans.
  • CMS has announced ongoing drug price negotiations affecting multiple medications, which could shift public-payer pricing for GLP-1s further over the next few years.

For a deeper walkthrough of Medicare-specific rules, Revive Meds has put together a GLP-1 insurance coverage checklist worth bookmarking before your next Part D renewal.

How to Estimate and Lower Your Semaglutide Cost, Step by Step

Getting a real number, instead of a guess pulled from a forum post, takes about 20 minutes of phone calls and a little paperwork. Here’s the order that actually works:

  1. Call your insurer’s member services line and ask specifically whether semaglutide is covered for your diagnosis (weight management versus diabetes matters here) and what tier it falls under.
  2. Ask your prescriber’s office to submit an electronic prior authorization (ePA) if your plan requires one. This step alone determines whether you pay a copay or the full rate.
  3. Check the manufacturer’s savings program page for your specific product and confirm you meet the eligibility criteria before assuming the advertised price applies to you.
  4. Call two or three pharmacies, including a mail-order option, and ask for the adjudicated price under your specific plan. Cash prices can vary by more than $100 between pharmacies in the same city.
  5. If you’re paying out of pocket, compare NovoCare self-pay pricing against a legitimate telehealth or compounding option using the safety checklist above before deciding.
  6. Use an HSA or FSA if you have one. Semaglutide prescribed for a diagnosed medical condition typically qualifies as an eligible expense.
  7. Ask about 90-day supplies through mail order, which sometimes lowers the effective monthly cost compared to filling one month at a time.

Pro Tip: Ask every pharmacy whether the quoted price includes needles, alcohol swabs, and a sharps container. Some injectable prescriptions ship without supplies, and a $15 supply kit can catch people off guard on their first order.

What Revive Meds Sees in the Semaglutide Pricing Conversation

Cost questions around semaglutide almost always come from a good instinct: patients want to know what they’re actually going to pay before they commit to months of treatment, not after the first invoice shows up. Revive Meds built its telehealth model around that same instinct.

Every patient goes through a full medical intake reviewed by a licensed clinician before any prescription is written, and every medication is compounded at FDA-registered U.S. pharmacies with 99%+ purity testing behind it. That combination matters because the cheapest option on the internet and the safest option on the internet aren’t always the same product, and patients deserve a provider that treats both questions as equally important. Delivery runs 48 to 72 hours, discreetly, with no membership fees layered on top of the medication cost itself.

What Revive Meds adds beyond the prescription is ongoing access. Unlimited provider messaging means a dose adjustment or a side-effect question doesn’t require another paid visit or a week of waiting, which is often where patients on other platforms lose money without realizing it.

— Amy

Get Clinician-Supervised Semaglutide Without the Guesswork on Pricing

Revive Meds gives you a fixed path to compounded GLP-1 therapy without membership fees, insurance denials, or the multi-call scramble described above. You complete a full medical intake, a licensed clinician reviews it, and if approved, your prescription ships from an FDA-registered U.S. pharmacy with 99%+ purity testing behind every batch.

Revive Meds

Same-day onboarding means you’re not waiting weeks for a first appointment slot, and the treatment is HSA/FSA eligible if you’re managing costs through one of those accounts. Delivery takes 48 to 72 hours, arrives discreetly, and your clinician stays reachable through unlimited messaging for dose adjustments or questions as your treatment progresses. There’s no membership fee sitting on top of your medication cost, and no one-size-fits-all protocol handed to you regardless of your history or goals.

If you’re ready to see what a personalized GLP-1 protocol looks like, start with the GLP-1 Squared program page and complete the intake to get a clinician’s assessment of your options.

Get Clinician-Supervised Semaglutide Without the Guesswork on Pricing — overview diagram

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

Sources